We first evaluated the performance of the single markers, including F. nucleatum and pks+ E. coli, as well as the conventional tumor markers CEA and CA19-9, to serve as individual markers in differentiating CRC from the controls (Table 3). The gene discussed is CEACAM5; the disease is colorectal carcinoma.